Side Effect Management
Weekly Fosaprepitant Betters Quality of Life During Chemoradiotherapy
August 2nd 2023Patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy reported higher quality of life and were less likely to experience vomiting when receiving fosaprepitant every week as opposed to every three weeks.
Palliative Care at Point of Cancer Surgery May Not Be Beneficial
May 17th 2023Palliative care — which focuses on quality of life — did not significantly improve outcomes in patients when delivered at the point of oncology surgery, highlighting the need to better understand when the best time to provide the service would be.